Qin, E., & Guilz, N. (2022). Using CRISPR-Cas9 In Human Fetuses to Prevent Trisomy 16 and Trisomy 22 Induced Miscarriages. Journal of Student Research, 11(4). https://doi.org/10.47611/jsrhs.v11i4.3859